-
About
Mass General- Hospital Overview
- Why Mass General
- In the Local & Global Community
- Massachusetts General Physicians Organization
- Multimedia
- News & Events
- Support Mass General
- Conditions
& Treatments- View All Conditions & Treatments
- View by Medical Category:
- Centers
& Services- Care Centers
- Departments
- Anesthesia, Critical Care
& Pain Medicine - Dermatology
- Emergency Medicine
- Imaging
- Medicine
- Molecular Biology
- Neurology
- Neurosurgery
- Obstetrics & Gynecology
- Anesthesia, Critical Care
- Facilities & Amenities
- Patient & Family Services
- Research
- View All Research Centers & Labs
- Research at Mass General
- Research News & Events
-
Clinical
Trials - Education
& Training- View All Fellowships, Residencies & CME
- Specialized Education & Training
- Education & Training Calendar
- Career
Opportunities
Philip Crawford Amrein, MD
- Phone: 617-724-3456
- Departments
- Hematology/Oncology
- Department of Medicine
Specialties
- Cancer Center
- Multiple Myeloma
- Leukemia
- Hematology
- Clinical Interests
- Acute leukemia
- Chronic leukemia
- Myelodysplasia
- Multiple myeloma
- Locations
- Boston: Massachusetts General Hospital
- Medical Education
- MD, Johns Hopkins University School of Medicine
- Residency, Waterbury Hospital Health Center
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
- Gender
- Male
- Patient Age Group
- Adult
- Accepting New Patients
- Yes
Publications1) Schiffer CA,...Amrein PC,..."A double-blind, placebo-controlled trial of pegylated recombinant MGDF as an adjunct to induction and consolidation therapy to patients with acute myeloid leukemia". Blood 2000;95:2530-2535.
2) Moore JO,...Amrein PC,...."Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: CALGB study 9222". Blood 2005;105:3420-3427.
3) Attar EC,...Amrein PC. "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with AML". Clinical Cancer Research 2008;14:1446-1454.
4) DeAngelo D,...Amrein PC,..."A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphocytic leukemia". Blood (ASH abstract #580) 2007.
5) Amrein PC, et al. "Dasatinib has activity in relapsed/refractory CLL/SLL". Blood (ASH abstract #3162) 2008.
100 Blossom Street
Boston, MA 02114
Phone: 617-724-3456
Phone 2: 617-726-8748
Fax: 617-643-1915
- © 2013 Massachusetts General Hospital
- 55 Fruit Street, Boston, MA 02114
- Maps & Directions
- 617-726-2000
- TDD: 617-724-8800
